Genprex to Present at Upcoming September Investor Conference

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Related Keywords

Texas , United States , , Drug Administration , Exchange Commission , Company Website , Genprex Inc , Linkedin , Facebook , Twitter , Highlight Company , Gene Therapies , Chief Financial Officer , Ryan Confer , Annual Global Investment , Chief Financial , Investor Relations , Nanoparticle Delivery System , Fast Track Designation , Language Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Genprex , Nc ,